Bolt Biotherapeutics
BOLT
BOLT
56 hedge funds and large institutions have $38.5M invested in Bolt Biotherapeutics in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 22 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
50% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 22
Holders
56
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$654K | |
| 2 | +$255K | |
| 3 | +$173K | |
| 4 |
PFMU
Privium Fund Management (UK)
London,
United Kingdom
|
+$172K |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$123K |
Top Sellers
| 1 | -$1.18M | |
| 2 | -$502K | |
| 3 | -$306K | |
| 4 |
NM
Newtyn Management
New York
|
-$219K |
| 5 |
Renaissance Technologies
New York
|
-$214K |